A novel drug may help relieve unexplained chronic cough – but at the expense of taste disorders, according to a study in The Lancet Respiratory Medicine. Results from a phase 2b randomised controlled trial found that gefapixant, a P2X3 receptor antagonist, reduced cough frequency by up to 37% compared to placebo in patients with a ...
Gefapixant gives a taste of what may work for unexplained chronic cough
By Michael Woodhead
4 Mar 2020